Experiences with

Adenocarcinoma

It’s stage 3a adenocarcinoma. Waiting for the treatment plan with the oncologist to start quickly. I feel 💔 Symptoms were ignored by medics last year and someone saw a growth last June in his lung and never told us. I just hope we can get treatment quickly and there’s a positive path ahead.

Apex : Adenocarcinoma (Gleason 6 (3+3)) Tumor length percent 50% D: Lat Base : Adenocarcinoma (Gleason 7 (3+4)) Tumor length percent 60% (May be PNI) E:Lat Mid : Adenocarcinoma (Gleason 7 (3+4)) Tumor length percent 65% F: Lat Apex: Adenocarcinoma (Gleason 6 (3+3)) Tumor length percent 50% G: Target

Apex : Adenocarcinoma (Gleason 6 (3+3)) Tumor length percent 50% D: Lat Base : Adenocarcinoma (Gleason 7 (3+4)) Tumor length percent 60% (May be PNI) E:Lat Mid : Adenocarcinoma (Gleason 7 (3+4)) Tumor length percent 65% F: Lat Apex: Adenocarcinoma (Gleason 6 (3+3)) Tumor length percent 50% G: Target

In a phase 1b/2 study (ClinicalTrials.gov Identifier: NCT03910660), BXCL701 was evaluated in combination with pembrolizumab, a PD-1 inhibitor, in mCRPC patients with adenocarcinoma phenotype as well as in small-cell neuroendocrine carcinoma (SCNC).

Male age 46 with recent discovery of adenocarcinoma arising in Tubulovillous adenoma, G3 differentiation, Tumor budding score (Bd2) imtermediate, tumor extension into the submucosa (SM1 level) Pathologicaal staging at this time is p T1, NX.

I’ve just been diagnosed with Metastatic adenocarcinoma of the lung and am starting palliative treatment of Carboplatin/Pemetrexed/Pembrolizumab therapy on Tuesday. This all has come completely out of the blue to me, and I understand very little of what I might expect.

The median survival for patients with metastatic castration resistant prostate adenocarcinoma is approximately 2 to 3 years."

Adenocarcinoma - Right Lat Base <5%, Left Mid 15%, Left Lat Mid 40%, Left Apex 10%, Right Apex 50% and Right Lateral Apex 15%. All with no Perineural or lymphovascular invasion. ROI - Adenocarcinoma approx 80% of tissue with perineural invasion and no lymphovascular.

I felt my biopsy pathology report was light on details: LT Anterior Base, Biopsy: Prostatic adenocarcinoma, Gleason score 3+3=6, involving 6mm and 70% of the submitted tissue RT Anterior Base, Biopsy: Prostatic adenocarcinoma, Gleason score 3+4=7, involving 4mm, 1 mm and 60% of the submitted tissue

Can it be Adenocarcinoma turn to small cells or Neuroendocrine? My dad’s bone metastasis when diagnostic of prostate cancer but only recently he feels hurt / uncomfortable at hip and / or leg. Thank you in advance for your sharing and comments.

2 years ago, when I was diagnosed with Stage 4 adenocarcinoma, a friend pointed me towards https://www.canceractive.com/article/using-phenergan-promethazine-to-treat-cancer which certainly looked interesting.

B PROSTATE, L APEX; CORE BIOPSY: INVASIVE PROSTATIC ADENOCARCINOMA, GLEASON SCORE 3 + 4 = 7, GRADE GROUP 2, (5% CRIBRIFORM GLANDS), INVOLVING ONE OF ONE CORE; 12 MM TUMOR LENGTH (90% OF PROSTATE CORE).

Results reveal tumor cells in iliac node positive for NKX 3.1 while INSM1 & synaptophysin "show very rare positive cells." and adenocarcinoma in one lung. A chromogranin A test shows an upward trend, from 52 (9/20) to 86 (11/21). We're meeting with his oncologist tomorrow.

Biopsy from TURP: Prostatic adenocarcinoma, Gleason score 4+5=9 (Grade Group 5), involving approximately 90% of submitted tissue. Focal mucinous features. Perineural invasion identified in this case. Intraductal carcinoma of the prostate identified.

He had brain metastasis due to complications of his adenocarcinoma turning to a neuroendocrine diferenciation. Even we tried our best, dad broke his hip so he was not eligible for receiving docetxactel either Thanks so much for all your support and your help during this journey

* Diagnosed in mid Sept 2021 * Gleason all 3-4 but one core was 4-3 with cancer on the nerve which spred to the bones T3, T4 and Iliac rib bone ridge all about 1cm or less * PSA 16 - * 7 0ut 12 cores had prostate adenocarcinoma * Started Lupron and Casodex Sept 22 * Oct 20th PSA 2.5 and Testoterone

Tumour was adenocarcinoma (80% lepedic 20% acinar) no detection of it spreading anywhere else.

Region of interest #1, A, needle biopsy: - Prostatic adenocarcinoma, Gleason Grade 3+3 = score of 6, involving 4 of 6 cores, measuring 6 mm in linear extent, 8% of tissue - See description Prostate, right lateral base, B, needle biopsy: - Prostatic adenocarcinoma, Gleason Grade 3+3 = score of 6

Below is pathology from RP- Prostate (Radical Prostatectomy, TS-19-05686, 2/4/2019): HISTOLOGIC TYPE Adenocarcinoma (conventional, NOS) GLEASON SCORE, DOMINANT NODULE 3+4=7 Grade Group 2 40% Pattern 4 (tertiary pattern 5) TUMOR EXTENT Tumor dimension (max): 24.0 mm LOCATION, DOMINANT NODULE

I haven't had a diagnosis of Ovarian Cancer myself, but I am a twice diagnosed patient myself- Wilms tumour in 1991 and Cervical adenocarcinoma in 2019, so finding out about new treatments on the trials I am involved with gives me hope for future patients.